1g5s: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="1g5s" size="450" color="white" frame="true" align="right" spinBox="true" caption="1g5s, resolution 2.61Å" /> '''CRYSTAL STRUCTURE O...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1g5s.gif|left|200px]]<br />
[[Image:1g5s.gif|left|200px]]<br /><applet load="1g5s" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1g5s" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1g5s, resolution 2.61&Aring;" />
caption="1g5s, resolution 2.61&Aring;" />
'''CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE INHIBITOR H717'''<br />
'''CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE INHIBITOR H717'''<br />


==Overview==
==Overview==
Cyclin-dependent kinases (CDKs) are regulatory proteins of the eukaryotic, cell cycle. They act after association with different cyclins, the, concentrations of which vary throughout the progression of the cell cycle., As central mediators of cell growth, CDKs are potential targets for, inhibitory molecules that would allow disruption of the cell cycle in, order to evoke an antiproliferative effect and may therefore be useful as, cancer therapeutics. We synthesized several inhibitory, 2,6,9-trisubstituted purine derivatives and solved the crystal structure, of one of these compounds, H717, in complex with human CDK2 at 2.6 A, resolution. The orientation of the C2-p-diaminocyclohexyl portion of the, inhibitor is strikingly different from those of similar moieties in other, related inhibitor complexes. The N9-cyclopentyl ring fully occupies a, space in the enzyme which is otherwise empty, while the C6-N-aminobenzyl, substituent points out of the ATP-binding site. The structure provides a, basis for the further development of more potent inhibitory drugs.
Cyclin-dependent kinases (CDKs) are regulatory proteins of the eukaryotic cell cycle. They act after association with different cyclins, the concentrations of which vary throughout the progression of the cell cycle. As central mediators of cell growth, CDKs are potential targets for inhibitory molecules that would allow disruption of the cell cycle in order to evoke an antiproliferative effect and may therefore be useful as cancer therapeutics. We synthesized several inhibitory 2,6,9-trisubstituted purine derivatives and solved the crystal structure of one of these compounds, H717, in complex with human CDK2 at 2.6 A resolution. The orientation of the C2-p-diaminocyclohexyl portion of the inhibitor is strikingly different from those of similar moieties in other related inhibitor complexes. The N9-cyclopentyl ring fully occupies a space in the enzyme which is otherwise empty, while the C6-N-aminobenzyl substituent points out of the ATP-binding site. The structure provides a basis for the further development of more potent inhibitory drugs.


==About this Structure==
==About this Structure==
1G5S is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with I17 as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1G5S OCA].  
1G5S is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=I17:'>I17</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1G5S OCA].  


==Reference==
==Reference==
Line 14: Line 13:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Bitonti, A.J.]]
[[Category: Bitonti, A J.]]
[[Category: Borcherding, D.R.]]
[[Category: Borcherding, D R.]]
[[Category: Dreyer, M.K.]]
[[Category: Dreyer, M K.]]
[[Category: Dumont, J.A.]]
[[Category: Dumont, J A.]]
[[Category: Kim, S.H.]]
[[Category: Kim, S H.]]
[[Category: Peet, N.P.]]
[[Category: Peet, N P.]]
[[Category: Shen, J.]]
[[Category: Shen, J.]]
[[Category: Tsay, J.T.]]
[[Category: Tsay, J T.]]
[[Category: Wright, P.S.]]
[[Category: Wright, P S.]]
[[Category: I17]]
[[Category: I17]]
[[Category: protein-inhibitor complex]]
[[Category: protein-inhibitor complex]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 17:01:05 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:46:27 2008''